Subscription Page.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. Suppl 7, p. NP, doi. 10.1093/cid/cir243
- Publication type:
- Article
Works matching IS 10584838 AND DT 2011 AND VI 52 AND IP Suppl 7
Results: 16
1
2
Editorial Board.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. Suppl 7, p. NP, doi. 10.1093/cid/cir242
- Publication type:
- Article
3
Cover.
- Published in:
- 2011
- Publication type:
- Cover Art
4
Table of Contents.
- Published in:
- 2011
- Publication type:
- Table of Contents
5
Pharmacokinetics and Safety of Single, Multiple, and Loading Doses of Fusidic Acid in Healthy Subjects.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. Suppl 7, p. S504, doi. 10.1093/cid/cir174
- By:
- Publication type:
- Article
6
Fusidic Acid Enters the United States.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. Suppl 7, p. NP, doi. 10.1093/cid/cir172
- Publication type:
- Article
7
Introduction: Fusidic Acid Enters the United States.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. Suppl 7, p. S467, doi. 10.1093/cid/cir171
- By:
- Publication type:
- Article
8
Efforts to Support the Development of Fusidic Acid in the United States.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. Suppl 7, p. S542, doi. 10.1093/cid/cir170
- By:
- Publication type:
- Article
9
Case Report: Treatment of Chronic Osteomyelitis.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
10
The Safety Record of Fusidic Acid in Non-US Markets: A Focus on Skin Infections.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. Suppl 7, p. S527, doi. 10.1093/cid/cir168
- By:
- Publication type:
- Article
11
A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. Suppl 7, p. S520, doi. 10.1093/cid/cir167
- By:
- Publication type:
- Article
12
Application of Pharmacokinetic-Pharmacodynamic Modeling and the Justification of a Novel Fusidic Acid Dosing Regimen: Raising Lazarus From the Dead.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. Suppl 7, p. S513, doi. 10.1093/cid/cir166
- By:
- Publication type:
- Article
13
Activity of Fusidic Acid Against Extracellular and Intracellular Staphylococcus aureus: Influence of pH and Comparison With Linezolid and Clindamycin.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. Suppl 7, p. S493, doi. 10.1093/cid/cir165
- By:
- Publication type:
- Article
14
Characterization of Global Patterns and the Genetics of Fusidic Acid Resistance.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. Suppl 7, p. S487, doi. 10.1093/cid/cir164
- By:
- Publication type:
- Article
15
In Vitro Antimicrobial Findings for Fusidic Acid Tested Against Contemporary (2008–2009) Gram-Positive Organisms Collected in the United States.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. Suppl 7, p. S477, doi. 10.1093/cid/cir163
- By:
- Publication type:
- Article
16
New Rules for Clinical Trials of Patients With Acute Bacterial Skin and Skin-Structure Infections: Do Not Let the Perfect Be the Enemy of the Good.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. Suppl 7, p. S469, doi. 10.1093/cid/cir162
- By:
- Publication type:
- Article